138 related articles for article (PubMed ID: 9219176)
1. Is there a correlation in breast carcinomas between tumor size and number of tumor vessels detected by gadolinium-enhanced magnetic resonance mammography?
Siewert C; Oellinger H; Sherif HK; Blohmer JU; Hadijuana J; Felix R
MAGMA; 1997 Mar; 5(1):29-31. PubMed ID: 9219176
[TBL] [Abstract][Full Text] [Related]
2. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
3. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.
Gribbestad IS; Nilsen G; Fjøsne HE; Kvinnsland S; Haugen OA; Rinck PA
J Magn Reson Imaging; 1994; 4(3):477-80. PubMed ID: 8061451
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
5. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
[TBL] [Abstract][Full Text] [Related]
6. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
Kaiser WA
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
[TBL] [Abstract][Full Text] [Related]
7. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent.
Boetes C; Mus RD; Holland R; Barentsz JO; Strijk SP; Wobbes T; Hendriks JH; Ruys SH
Radiology; 1995 Dec; 197(3):743-7. PubMed ID: 7480749
[TBL] [Abstract][Full Text] [Related]
8. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
9. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.
Brinck U; Fischer U; Korabiowska M; Jutrowski M; Schauer A; Grabbe E
AJR Am J Roentgenol; 1997 May; 168(5):1331-4. PubMed ID: 9129437
[No Abstract] [Full Text] [Related]
10. A fast 3D-imaging technique for performing dynamic Gd-enhanced MRI of breast lesions.
Perman WH; Heiberg EM; Grunz J; Herrmann VM; Janney CG
Magn Reson Imaging; 1994; 12(4):545-51. PubMed ID: 8057758
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of tumor angiogenesis with contrast-enhanced dynamic magnetic resonance mammography.
Tuncbilek N; Unlu E; Karakas HM; Cakir B; Ozyilmaz F
Breast J; 2003; 9(5):403-8. PubMed ID: 12968962
[TBL] [Abstract][Full Text] [Related]
12. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation.
Fobben ES; Rubin CZ; Kalisher L; Dembner AG; Seltzer MH; Santoro EJ
Radiology; 1995 Jul; 196(1):143-52. PubMed ID: 7784558
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
[TBL] [Abstract][Full Text] [Related]
14. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
[TBL] [Abstract][Full Text] [Related]
15. [Subtraction and dynamic MR images of breast cancer].
Murakami Y; Aoki M; Harada J
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):375-86. PubMed ID: 8493070
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI.
Alamo L; Fischer U
Eur Radiol; 2001; 11(6):970-7. PubMed ID: 11419173
[TBL] [Abstract][Full Text] [Related]
17. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis.
Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Toyoshima S; Masuda K; Kuroki S; Ohno S
J Comput Assist Tomogr; 1997; 21(3):421-30. PubMed ID: 9135652
[TBL] [Abstract][Full Text] [Related]
18. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
[TBL] [Abstract][Full Text] [Related]
19. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer.
Fischer U; Kopka L; Brinck U; Korabiowska M; Schauer A; Grabbe E
Eur Radiol; 1997; 7(7):1002-5. PubMed ID: 9265662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
